Combined bezafibrate, medroxyprogesterone acetate and valproic acid treatment inhibits osteosarcoma cell growth without adversely affecting normal mesenchymal stem cells

Jonathan J. Sheard, Andrew D. Southam, Hannah L. MacKay, Max A. Ellington, Martyn D. Snow, Farhat L. Khanim, Christopher M. Bunce, William E. Johnson*

*Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

128 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Combined bezafibrate, medroxyprogesterone acetate and valproic acid treatment inhibits osteosarcoma cell growth without adversely affecting normal mesenchymal stem cells'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry